Dermatology Images
Buy and sell dermatology images data. Skin lesion photos with biopsy-confirmed diagnoses. Skin cancer detection AI needs diverse, labeled dermatology image datasets.
No listings currently in the marketplace for Dermatology Images.
Find Me This Data →Overview
What Is Dermatology Images Data?
Dermatology images data comprises high-resolution skin lesion photographs collected from clinical settings and labeled with biopsy-confirmed or expert-consensus diagnoses. These datasets are essential for developing and validating AI systems that detect skin cancer and other dermatological conditions. Images are captured using dermatoscopes, DSLR cameras, and mobile devices with dermatoscope attachments, then undergo rigorous quality assurance and expert annotation to ensure diagnostic accuracy. The data supports both clinical reference and computational machine learning applications across hospitals, dermatology centers, and research institutions.
Market Data
$815.5 million
U.S. Dermatology Imaging Devices Market Size (2023)
Source: Grand View Research
$1,933.5 million
Projected Market Size (2030)
Source: Grand View Research
13.50% CAGR
Market Growth Rate (2024–2030)
Source: Grand View Research
12,345 dermatoscopic images from 1,627 patients
Largest Dataset Size (DERM12345)
Source: Nature
~9,500 individuals
Daily U.S. Skin Cancer Cases
Source: Grand View Research
Who Uses This Data
What AI models do with it.do with it.
AI Model Development for Skin Cancer Detection
Machine learning engineers and AI researchers use labeled dermatology images to train and validate models that automatically detect melanoma, basal cell carcinoma, and squamous cell carcinoma with high diagnostic accuracy.
Clinical Diagnostic Support in Dermatology Centers
Dermatology centers and hospitals deploy AI-integrated dermatoscopes to enhance diagnostic accuracy and efficiency, supporting dermatologists with second-opinion capabilities during skin lesion evaluations.
Regulatory Approval and Compliance
Medical device manufacturers developing AI diagnostic platforms require diverse, biopsy-confirmed datasets to obtain regulatory clearance and CE marking under EU MDR standards.
Clinical Research and Dataset Publication
Academic medical centers and research institutes contribute annotated dermatology images to open-access datasets that advance dermatological knowledge and support peer-reviewed scientific publications.
What Can You Earn?
What it's worth.worth.
Entry-Level Dataset (Smaller Collections)
Varies
Smaller proprietary datasets with 500–2,000 biopsy-confirmed images typically command lower per-image rates depending on diagnostic diversity and tissue type coverage.
Mid-Tier Dataset (Standard Commercial Use)
Varies
Collections of 5,000–15,000 images with multi-class diagnoses and ethical approvals attract buyers focused on model validation and regulatory submissions.
Enterprise Dataset (Large, Diverse Collections)
Varies
Premium datasets exceeding 10,000 images with extensive skin type diversity, high-resolution captures, and multiple diagnostic confirmations command premium pricing for enterprise AI development and clinical integration.
What Buyers Expect
What makes it valuable.valuable.
Image Clarity and Resolution
All images must be clear, in focus, and of sufficient resolution to preserve diagnostic features visible to expert dermatologists. Poor-quality, blurred, or low-magnification images are excluded.
Biopsy or Expert Confirmation
Only images with histopathological confirmation or consensus diagnosis by two independent expert dermatologists qualify. Follow-up clinical validation is also acceptable when biopsy is unavailable.
Diverse Skin Types and Lesion Classes
Datasets must represent varied skin phototypes and a broad range of dermatological conditions to ensure AI models generalize across patient populations and reduce diagnostic bias.
Ethical Approval and Regulatory Compliance
Images require institutional ethics review board approval, patient consent documentation, and compliance with regional medical device regulations (e.g., EU MDR, FDA standards). Proper data anonymization and pseudonymization are mandatory.
Standardized Annotation and Metadata
Each image must include verified diagnostic labels, acquisition device information, patient demographics (where permissible), and any relevant clinical history to support model training and validation.
Companies Active Here
Who's buying.buying.
Develops AI-integrated dermatoscopes and imaging platforms for skin lesion evaluation; has obtained CE marking under EU MDR and uses clinical datasets to enhance diagnostic algorithms.
Major provider of advanced dermatology imaging technologies deployed across hospitals and healthcare networks for diagnostic imaging and AI-supported clinical workflows.
Operates in the dermatology imaging devices market, providing clinical imaging systems used in diagnostic and research settings.
Manufactures hand-held dermatoscopes and digital imaging systems widely used in clinical data collection for diagnostic and research applications.
Develops dermatology AI diagnostic platforms; has successfully navigated EU regulatory pathways and leverages clinical datasets for model development.
FAQ
Common questions.questions.
What makes a dermatology image dataset valuable for AI development?
High-value datasets combine large image counts (5,000+), biopsy-confirmed or expert-consensus diagnoses, diverse skin types, high resolution and clarity, and comprehensive metadata. Ethical approvals and regulatory compliance significantly increase commercial value.
Who are the primary buyers of dermatology image datasets?
Primary buyers include AI/ML companies developing diagnostic platforms, medical device manufacturers seeking regulatory approval, dermatology software vendors, hospitals and clinic networks deploying AI-assisted imaging, and academic research institutions publishing peer-reviewed studies.
What regulatory certifications do dermatology AI datasets need?
Datasets should support products meeting FDA 510(k) or EU MDR CE marking requirements. Current Procedural Terminology (CPT) codes for AI-assisted skin lesion evaluation were established in 2021 and support reimbursement pathways. Institutional ethics board approval and patient consent documentation are mandatory.
What is the current market opportunity for dermatology imaging data?
The U.S. dermatology imaging devices market reached $815.5 million in 2023 and is projected to grow at 13.50% CAGR to $1,933.5 million by 2030, driven by rising skin cancer incidence, technological advancement, and adoption of AI-integrated diagnostic tools in dermatology centers and hospitals.
Sell yourdermatology imagesdata.
If your company generates dermatology images, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation